Study to Evaluate the Efficacy of Riluzole in Children and Young Adults With Spinal Muscular Atrophy (SMA)
Status:
Completed
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
This is a multicentric, randomized, double-blind study versus placebo, with two parallel
groups treated to evaluate the efficacy and the tolerance of Riluzole in children and young
adults (6 to 20 years of age) with SMA. (Type II and Type III).